MIXED DYSLIPIDEMIA
Clinical trials for MIXED DYSLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new MIXED DYSLIPIDEMIA trials appear
Sign up with your email to follow new studies for MIXED DYSLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cholesterol drug inclisiran tested in Real-World patients
Disease control OngoingThis study tracks 847 adults with high cholesterol or mixed dyslipidemia who are taking inclisiran along with other cholesterol medications. The goal is to see how much their LDL (bad) cholesterol drops after 10 months and how well they stick to the treatment. It is an observatio…
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 08:48 UTC
-
New injection shows promise for lowering dangerous blood fats
Disease control OngoingThis study tests a new drug called BW-00112 in 145 adults with mixed dyslipidemia, a condition where blood fat levels are too high. Participants receive injections of the drug or a placebo to see if it safely lowers triglycerides over 6 months. All participants are already on a s…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE2 • Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Will breakfast change your medicine? new study tests Food-Drug interaction
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how taking a new drug (AD-117) with or without food changes its safety and levels in the body. About 60 healthy adults will each receive a single dose under both conditions. The goal is to understand food effects, not to treat any disease.
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE1 • Sponsor: Addpharma Inc. • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC
-
New cholesterol drug under Real-World watch in asia and latin america
Knowledge-focused OngoingThis study tracks over 2,500 adults with high cholesterol who are taking bempedoic acid (alone or with ezetimibe) in routine medical care. Researchers want to see how safe the drug is and how it affects heart risk, especially in Asian and Latin American patients. No new treatment…
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Daiichi Sankyo • Aim: Knowledge-focused
Last updated May 11, 2026 20:50 UTC
-
New cholesterol drug under Real-World microscope
Knowledge-focused OngoingThis study follows 5,000 adults with high cholesterol who are taking bempedoic acid (alone or with ezetimibe) in everyday medical practice. Researchers will track how well the drug lowers cholesterol, any side effects, and heart-related events over one year or more. The goal is t…
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC